In contrast, low or undetectable levels of PDX-1 have been reported in primary tumors and normal colonic tissue, suggesting its potential role as a biomarker for CRC diagnosis and progression [38,39,40]. This evidence concerns the gene PDX1 and colorectal carcinoma.